New data for patients with HER2-positive early stage breast cancer were reported in two important studies at the recent 2019 San Antonio Breast Cancer Symposium.
Virginia Kaklamani, M.D., leader of the breast cancer program at UT Health San Antonio and co-leader of the San Antonio Breast Cancer Symposium, is featured in this video about new clinical trial data presented at symposium.